Lauren F. Uchiyama

Lauren F. Uchiyama

Auto-generated profile, based on publicly available information

Lauren F. Uchiyama

Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2016 in Science
Verified
Journal Article
Closed access
PDF file
SLSamantha C. Lewis
Samantha C. Lewis
LULauren F. Uchiyama
Lauren F. Uchiyama
JNJodi Nunnari
Jodi Nunnari
How the ER manages mitochondrial division: It has been unclear how mitochondrial DNA (mtDNA) replication is spatially controlled in mammalian cells and how the mitochondrial nucleoid—the protein-DNA structure that is the unit of mtDNA inheritance—is distributed at the cellular level. Lewis et al. now show that homeostatic mtDNA synthesis in mitochondrial nucleoids in mammalian cells is spatially linked to a small subset of endoplasmic reticulum (ER)-mitochondria contact sites that are specifically destined for mitochondrial division. Successive events of mtDNA replication, mitochondrial division, and mitochondrial motility function together to ensure the accurate distribution of mtDNA in cells. Furthermore, ER-mitochondria contacts coordinate the licensing of mtDNA replication with division to distribute newly replicated nucleoids to daughter mitochondria. Science , this issue p. 261

7 December 2022 in Nature
Verified
Journal Article
Closed access
PDF file
KQKevin Qian
Kevin Qian
MTMarcus J. Tol
Marcus J. Tol
JWJin Wu
Jin Wu
LULauren F. Uchiyama
Lauren F. Uchiyama
XXXu Xiao
Xu Xiao
PTPeter Tontonoz
Peter Tontonoz

1 May 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
AMA. Mallat
A. Mallat
LUL.F. Uchiyama
L.F. Uchiyama
SLS.C. Lewis
S.C. Lewis
RFR.A. Fredenburg
R.A. Fredenburg
YTY. Terada
Y. Terada
CTC.C. Tseng
C.C. Tseng

9 October 2025 in Science
Verified
Journal Article
Closed access
YGYajing Gao
Yajing Gao
JKJohn P. Kennelly
John P. Kennelly
XXXu Xiao
Xu Xiao
EWEmily Whang
Emily Whang
AFAlessandra Ferrari
Alessandra Ferrari
PTPeter Tontonoz
Peter Tontonoz
The intrinsic pathways that control membrane organization in immune cells and their impact on cellular functions are poorly defined. We found that the nonvesicular cholesterol transporter Aster-A linked plasma membrane (PM) cholesterol availability in CD4 T cells to systemic metabolism. Aster-A was recruited to the PM during T cell receptor (TCR) activation, where it facilitated the removal of accessible cholesterol. Loss of Aster-A increased cholesterol accumulation in the PM, which enhanced TCR nanoclustering and signaling. Aster-A associated with stromal interaction molecule 1 (STIM1) and negatively regulated calcium (Ca 2+ ) flux. Aster-A deficiency promoted CD4 T cells to acquire a T helper 17 (T H 17) phenotype and stimulated interleukin-22 production, which reduced intestinal fat absorption and conferred resistance to diet-induced obesity. These findings delineate how immune cell membrane homeostasis links to systemic physiology.

21 April 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LULauren F. Uchiyama
Lauren F. Uchiyama
ANAlexander Nguyen
Alexander Nguyen
KQKevin Qian
Kevin Qian
LCLiujuan Cui
Liujuan Cui
KPKhoi T. Pham
Khoi T. Pham
PTPeter Tontonoz
Peter Tontonoz
Ketogenesis requires fatty acid flux from intracellular (lipid droplets) and extrahepatic (adipose tissue) lipid stores to hepatocyte mitochondria. However, whether interorganelle contact sites regulate this process is unknown. Recent studies have revealed a role for Calsyntenin-3β (CLSTN3β), an endoplasmic reticulum–lipid droplet contact site protein, in the control of lipid utilization in adipose tissue. Here, we show that Clstn3b expression is induced in the liver by the nuclear receptor PPARα in settings of high lipid utilization, including fasting and ketogenic diet feeding. Hepatocyte-specific loss of CLSTN3β in mice impairs ketogenesis independent of changes in PPARα activation. Conversely, hepatic overexpression of CLSTN3β promotes ketogenesis in mice. Mechanistically, CLSTN3β affects LD–mitochondria crosstalk, as evidenced by changes in fatty acid oxidation, lipid-dependent mitochondrial respiration, and the mitochondrial integrated stress response. These findings define a function for CLSTN3β-dependent membrane contacts in hepatic lipid utilization and ketogenesis.

15 April 2025 in Journal of Lipid Research
Verified
Journal Article
Open access
LULauren F. Uchiyama
Lauren F. Uchiyama
GOGabriel P.M. Ordonez
Gabriel P.M. Ordonez
KPKhoi T. Pham
Khoi T. Pham
JKJohn P. Kennelly
John P. Kennelly
MRMaykel López Rodríguez
Maykel López Rodríguez
ANAlexander Nguyen
Alexander Nguyen
Human single nucleotide variants in peroxisome proliferator-activated receptor-ɑ (PPARɑ) have been associated with beneficial metabolic phenotypes, yet their specific effects on metabolic gene expression are not well defined. Here, we developed a mouse model of a human PPARɑ variant encoding a substitution of valine for alanine at position 227 (V227A) to explore the role of this variant on systemic metabolism. Substitution with this variant in mice reduced plasma triglycerides, without altering body mass or liver lipid accumulation, consistent with phenotypes observed in human cohorts. Gene expression analysis revealed that the V227A variant enhances Ppara target gene expression in mouse liver, consistent with the effects of synthetic PPARɑ agonist treatment. Notably, V227A increased hepatic expression of Lpl, the predominant enzyme responsible for circulating triglyceride hydrolysis. Further characterization revealed that heart tissue from variant mice exhibited increased Lpl expression and triglyceride hydrolysis activity, suggesting that V227A enhances cardiac triglyceride clearance. These findings validate human observational studies and clarify the physiological impact of the V227A PPARɑ variant on plasma triglycerides.